Global Bioenergies extends the use of its bio-sourced isododecane to skincare and haircare products
In October 2020, an initial phase of toxicological studies paved the way for the use of naturally sourced isododecane produced by Global Bioenergies in the make-up segment.
The 2020 study has now been supplemented by a new toxicological assessment conducted in cooperation with an independent appraisal firm and completed today. The latest assessment approves the use of Global Bioenergies’ renewable isododecane in skincare and haircare products, sectors in which isododecane is used in much higher volumes than in the make-up sector. This new phase will allow Global Bioenergies to broaden its proposal to the giants of the beauty and personal care industry in order to increase the overall naturalness of the cosmetics sector.
From 2022 onwards, Global Bioenergies will increase production volumes thanks to the Pomacle unit, which will allow it to serve the make-up market while providing samples to the skincare and haircare markets.
In late 2024, a larger-capacity production plant, plans for which are currently under review, will start operating in order to fully serve these markets.
Marc Delcourt, Chief Executive Officer and co-founder of Global Bioenergies, said: “We are pursuing our step-by-step strategy of expansion: the first horizon was reached in 2021 with the launch of our own brand, LAST®. In early 2022, we plan to reach the second horizon by starting production at the Pomacle unit in order to serve the niche market for make-up ingredients, a high-value market but with limited volumes. By preparing to serve the much bigger skincare and haircare markets, we are already looking ahead to the third horizon scheduled for 2024.”